Showing results (601-610 of 1,373) with videos related to
Sort By:
Pageof 138
Drug Development Research|February 13, 2024
Bazedoxifene analogs as potential WDHD1 degraders and antitumor agents: Synthesis, evaluation and molecular dynamics simulation studiesLeyuan Chen, Gaiting Liu, Fancui Meng, et al.Drug Development Research|February 13, 2024
Design and synthesis of vancomycin-functionalized ZnFe2 O4 nanoparticles as an effective antibacterial agent against methicillin-resistant Staphylococcus aureusMinoo Akbari, Ali Hossein Rezayan, Hossein Rastegar, et al.Drug Development Research|February 13, 2024
Combined chemotherapy of zoledronic acid and pamidronate in the treatment of bone metastases from nonsmall cell lung cancer and the effects on pain stress and bone metabolic indicesKun Huang, Xiao Tang, Fang TangDrug Development Research|February 13, 2024
N-Substituted piperazine-coupled imidazo[2,1-b]thiazoles as inhibitors of Mycobacterium tuberculosis: Synthesis, evaluation, and docking studiesNagaraju Chirra, Naga Pranathi Abburi, Estharla Madhu Rekha, et al.Drug Development Research|February 13, 2024
Dendrobine regulates STAT3 to attenuate mitochondrial dysfunction and senescence in vascular endothelial cells triggered by oxidized low-density lipoproteinJia Xia, Jingyi Chen, Xinyue Xing, et al.Drug Development Research|May 27, 2024
Asprosin aggravates nonalcoholic fatty liver disease via inflammation and lipid metabolic disturbance mediated by reactive oxygen speciesChaowen Wang, Wenjing Zeng, Li Wang, et al.Drug Development Research|May 29, 2024
Repurposing of drugs against bacterial infections: A pharmacovigilance-based data mining approachSimran Ohra, Ruchika Sharma, Anoop KumarDrug Development Research|June 4, 2024
Explore new quinoxaline pharmacophore tethered sulfonamide fragments as in vitro α-glucosidase, α-amylase, and acetylcholinesterase inhibitors with ADMET and molecular modeling simulationAhmed Ragab, Mohamed A Salem, Yousry A Ammar, et al.Drug Development Research|April 29, 2024
A review of natural products and small-molecule therapeutics acting on central nervous system malignancies: Approaches for drug development, targeting pathways, clinical trials, and challengesArdalan Pasdaran, Irwin Darren Grice, Azadeh HamediDrug Development Research|April 28, 2024
Anti-NSCLC role of SCN4B by negative regulation of the cGMP-PKG pathway: Integrated utilization of bioinformatics analysis and in vitro assay validationXiujun Yang, Qun Liu, Gang LiPageof 138